WORLD DIAGNOSTICS INC
8-K, 2000-06-27
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Previous: ING FUNDS TRUST, NSAR-A, EX-27, 2000-06-27
Next: WORLD DIAGNOSTICS INC, 8-K, 2000-06-27



                       SECURITIES AND EXCHANGE COMMISSION


                             Washington, D.C. 20549

                                    FORM 8-K



                                 CURRENT REPORT



                         Pursuant to Section 13 or 15(d)
                     of the Securities Exchange Act of 1934




                                  June 21, 2000
                                 Date of Report
                      (Date of earliest event reported)



                           WORLD DIAGNOSTICS, INC.
                           -----------------------
            (Exact name of registrant as specified in its charter)


              Delaware             000-27627              65-0742342
        ------------------       -------------        ---------------
          (State or other         (Commission           (IRS Employer
          jurisdiction of         File Number)       Identification No.)
          incorporation)


              15271 N.W. 60th AVENUE, MIAMI LAKES, FLORIDA 33014
              --------------------------------------------------
            (Address of registrant's principal executive offices)




                                (305) 827-3304
                                --------------
             (Registrant's telephone number, including area code)


<PAGE>



Items 5.    Other Events.

WORLD DIAGNOSTICS, INC.
COMPLETES $500,000 PRIVATE PLACEMENT OF EQUITY UNITS

The Company  completed a private  placement of $500,000,  consisting of units of
3,572  shares  of the  Company's  Common  Stock  priced  at $7.00  per share and
warrants,  exercisable at $7.00 per share or  exchangeable,  without  additional
cash consideration,  but subject to certain restrictions and lock-up provisions,
for an  additional  3,572 shares per unit of the  Company's  Common  Stock.  The
proceeds will be used for general working capital purposes.



                           FORWARD LOOKING STATEMENTS


Statements  used in this press  release  that  relate to future  plans,  events,
financial reports or performance are forward-looking statements as defined under
the private Securities  Litigation Reform Act of 1995. Actual results may differ
materially  from those  anticipated as a result of certain risks,  uncertainties
and  assumptions,  including,  but not  limited  to,  market  acceptance  of the
Company's   products,   adverse  economic  and  market  conditions,   government
regulation   and   regulatory   uncertainties,   as  well  as  other  risks  and
uncertainties  detailed from time to time in the Company's periodic repots filed
with the Securities and Exchange Commission.  Readers are cautioned not to place
undue reliance on these forward-looking  statements,  which speak only as of the
date hereof.  World  Diagnostics  Inc.  undertakes no obligation to republish or
revise forward-looking statements to reflect anticipated or unanticipated events
or circumstances after the date hereof.




                                    SIGNATURE

Pursuant  to the  requirements  of the  Securities  Exchange  Act of  1934,  the
Registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned hereunto duly authorized.

                                    WORLD DIAGNOSTICS, INC.


                                    By:   /s/ Ken Peters
                                          ------------------------------------
                                          Ken Peters
                                          President


Date: June 27, 2000



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission